NWF Advisory Services Inc.

Position in JNJ — Johnson & Johnson

CIK 2045735 Los Angeles, CA

Position in JNJ

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$2,410,937

+$206,822 QoQ

Shares Held

9,493

+5.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.44%

of 13F equity value

Holder Rank

#2,193

of 4,676 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

NWF Advisory Services Inc. holds $14,660,430 across 10 Drug Manufacturers - General names. JNJ ranks #3 (16.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	12,825	$3,227,283
2	LLY	ELI LILLY & Co	2,136	$2,561,982
3	JNJ	Johnson & Johnson This page	9,493	$2,410,937
4	AMGN	Amgen Inc	5,766	$2,087,983
5	MRK	Merck & Co., Inc.	14,785	$1,899,872
6	PFE	Pfizer Inc	38,937	$937,602
7	AZN	Astrazeneca PLC	3,332	$631,813
8	BMY	Bristol Myers Squibb Co	6,255	$360,413

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,410,937	9,493	+5.3%	Shares	Sole	2026-07-29
2026-03-31	$2,204,115	9,017	-2.8%	Shares	Sole	2026-05-04
2025-12-31	$1,919,668	9,276	+3.8%	Shares	Sole	2026-03-03
2025-09-30	$1,657,469	8,939	-9.2%	Shares	Sole	2025-10-31
2025-06-30	$1,504,587	9,850	+69.6%	Shares	Sole	2025-09-09
2025-03-31	$963,364	5,809	-9.4%	Shares	Sole	2025-08-12
2024-12-31	$926,869	6,409	-2.5%	Shares	Sole	2025-05-14
2024-09-30	$1,065,706	6,576	+21.7%	Shares	Sole	2025-10-06
2024-06-30	$789,702	5,403	-1.8%	Shares	Sole	2025-10-06
2024-03-31	$870,203	5,501	+0.5%	Shares	Sole	2025-10-06
2023-12-31	$857,994	5,474	+5.1%	Shares	Sole	2025-12-08
2023-09-30	$811,301	5,209	+3.4%	Shares	Sole	2025-12-08
2023-06-30	$834,220	5,040	0.0%	Shares	Sole	2025-12-08
2023-03-31	$781,200	5,040	—	Shares	Sole	2025-12-08
No filing history on record for this holder in this stock.